CHP1 promotes lipid droplet growth and regulates the localization of key enzymes for triacylglycerol synthesis

G Guang Yang X Ximing Du (Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales) D Dougall Norris (Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales) A Armella Zadoorian (Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales) Y Yuyuan Zheng (School of Public Health and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine) M Mingming Gao A Andrew J. Brown (Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales) S Shane T. Grey (Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales) C Chun Zhou (School of Public Health and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine) H Hongyuan Yang

Abstract

The glycerol-3-phosphate (G-3-P) pathway is central to the synthesis of triacylglycerols (TAGs) and glycerophospholipids, essential for membrane biogenesis and lipid storage. The first and rate-limiting step in this pathway is catalyzed by glycerol-3-phosphate acyltransferases (GPATs), with microsomal GPAT3 and GPAT4 being evolutionarily conserved and predominant in most tissues. While previous studies have implicated Calcineurin B homologous protein 1 (CHP1) as a cofactor for GPAT4, the broader role of CHP1 in regulating microsomal GPATs and TAG biosynthesis remains unclear. Here, we demonstrate that CHP1 is a critical regulator of both GPAT3 and GPAT4, essential for their stability, enzymatic activity, and lipid droplet (LD) localization. Structural modeling and mutational analyses identified key hydrophobic interfaces mediating the CHP1–GPAT interaction, which are required for optimal GPAT activity and LD growth. Loss of CHP1 impairs LD expansion and disrupts the localization of GPAT3/4 and downstream enzymes in the TAG synthesis pathway, including 1-acylglycerol-3-phosphate O-acyltransferase 3 (AGPAT3) and diacylglycerol O-acyltransferase 2 (DGAT2). Mechanistically, CHP1 helps circumvent seipin-mediated restriction of late LD-targeting enzymes, facilitating their access to mature LDs. Together, our findings reveal CHP1 as a dual-function regulator that stabilizes and activates microsomal GPATs while enabling the coordinated recruitment of TAG biosynthetic enzymes to LDs. This work uncovers a previously unrecognized mechanism for regulating LD growth and glycerolipid metabolism, with broad implications for lipid homeostasis and metabolic diseases.

Article Details

Volume / Issue Vol. 122, Issue 35
Published September 02, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

G

Guang Yang

X

Ximing Du

Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales

D

Dougall Norris

Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales

A

Armella Zadoorian

Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales

Y

Yuyuan Zheng

School of Public Health and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

M

Mingming Gao

A

Andrew J. Brown

Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales

S

Shane T. Grey

Faculty of Science, School of Biotechnology and Biomolecular Sciences, The University of New South Wales

C

Chun Zhou

School of Public Health and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

H

Hongyuan Yang